Treace Medical Concepts, Inc.

TMCI - Financial Snapshot

Healthcare sector | Medical Devices industry

View on:
Ranks:

Metrics for TMCI

Price $2.7
Shares Outstanding 63.72M

Balance Statement Metrics

Net Cash / Share $0
cashValuePerShare = (Cash + Short Term Investments - Total Liabilities) / Shares Outstanding
Net Current Assets / Share $0.48
netCurrentAssetsPerShare = (Current Assets - Total Liabilities) / Shares Outstanding
Net Tangible Assets / Share $1.08
netTangibleAssetsPerShare = (Total Assets - Intangibles - Total Liabilities) / Shares Outstanding

Income Metrics

Max Earning Power / Share $-1.82
maxEarningPowerPerShare = (EBITDA / EP_MULTIPLIER) / Shares Outstanding
Adjusted Earning Power $-2.43
adjustedEarningPower = (Net Income / EP_MULTIPLIER) / Shares Outstanding
Non-Cash Charges to Market Cap 1.56%
nonCashChargeToMKTCAP = Non-Cash Charges / Market Capitalization
Data as of: Price 01-14-26 16:00 ET, Balance Sheet 2025-09-30, Income Statement 2025-09-30, Cash Flow 2025-09-30

Indicators

Dividend indicators Value Date
Pays Dividend No 12-21-2025
Income indicators Value Date
EBITDA Positive No 12-21-2025
Net Income Positive No 12-21-2025
Avg CA Burn (Annual %) 8.92% 12-21-2025
Avg CA Burn (Quarterly %) -3.19% 12-21-2025

Shares Outstanding Changes

Date Shares Outstanding Delta
No recent share changes

Interesting Volume Days

Date Volume Shares Outstanding Volume / Shares Price
No interesting volume events

Treace Medical Concepts, Inc., a medical technology company, designs, manufactures, and markets medical devices in the United States. The company offers Lapiplasty 3D bunion correction system that combines instruments, implants, and surgical methods designed to correct three planes of the bunion deformity and secure the unstable joint, addressing the root cause of the bunion. It also provides Lapiplasty mini-incision system designed to allow the Lapiplasty procedure to be performed through a 3.5cm incision. In addition, the company offers Adductoplasty system designed for reproducible correction of metatarsus adductus deformities and osteoarthritis of the midfoot. It serves physicians, surgeons, ambulatory surgery centers and hospitals related to the surgical management of bunion and related midfoot deformities. Treace Medical Concepts, Inc. was founded in 2013 and is headquartered in Ponte Vedra, Florida.